Characterizing the Efficacy and Safety of Chemotherapy Plus Everolimus in HER2-Negative Metastatic Breast Cancer Harboring Altered PI3K/AKT/mTOR

For Authors|For Editors|For Reviewers

Rong Wang, Qiao-Yan Zhu, Wei-Wu Ye, Yuan Huang, Zhan-Hong Chen, Ya-Bing Zheng, Xiao Zou, Jian Wang, Dan-Lu Jiang, Xiao-Jia Wang, Zheng-Yang Xu, Wen-Ming Cao

Discovery Medicine . 2024, (182): 527 -537 . DOI: 10.24976/Discov.Med.202436182.49

About Discovery Medicine
Editorial Board
Article Processing Charge
Submit

For Authors
For Editors
For Reviewers

Open Access Statement
Copyright & License
Digital Archive

Latest Issue
All Issues
Special Issues

By using this website, you agree to our Terms & Conditions and Privacy Policy.

Disclaimer

The statements, opinions and data contained in Discovery Medicine are solely those of the individual authors and contributors and not of the journal and the editor(s). Discovery Medicine stays neutral with regard to jurisdictional claims in published maps and insitutional affiliations.